UM

Browse/Search Results:  1-10 of 24 Help

Selected(0)Clear Items/Page:    Sort:
Cyclin B1 stability is increased by interaction with BRCA1, and its overexpression suppresses the progression of BRCA1-associated mammary tumors Journal article
Experimental and Molecular Medicine, 2018,Volume: 50,Page: 136
Authors:  Choi, Eun Kyung;  Lim, Jeong-A;  Kim, Jong Kwang;  Jang, Moon Sun;  Kim, Sun Eui;  Baek, Hye Jung;  Park, Eun Jung;  Kim, Tae Hyun;  Deng, Chu-Xia;  Wang, Rui-Hong;  Kim, Sang Soo
Favorite | View/Download:40/0 | TC[WOS]:2 TC[Scopus]:4 | Submit date:2018/10/30
Cyclin B1 stability is increased by interaction with BRCA1, and its overexpression suppresses the progression of BRCA1-associated mammary tumors Journal article
Experimental and Molecular Medicine, 2018,Volume: 50,Issue: 10
Authors:  Choi,Eun Kyung;  Lim,Jeong A.;  Kim,Jong Kwang;  Jang,Moon Sun;  Kim,Sun Eui;  Baek,Hye Jung;  Park,Eun Jung;  Kim,Tae Hyun;  Deng,Chu Xia;  Wang,Rui Hong;  Kim,Sang Soo
Favorite | View/Download:75/0 | TC[WOS]:3 TC[Scopus]:3 | Submit date:2020/09/16
Downregulation of Cyclin B1 mediates nagilactone E-induced G2 phase cell cycle arrest in non-small cell lung cancer cells Journal article
EUROPEAN JOURNAL OF PHARMACOLOGY, 2018,Volume: 830,Page: 17-25
Authors:  Zhang, Le-Le;  Feng, Zhe-Ling;  Su, Min-Xia;  Jiang, Xiao-Ming;  Chen, Xiuping;  Wang, Yitao;  Li, Ao;  Lin, Li-Gen;  Lu, Jin-Jian
View | Adobe PDF | Favorite | View/Download:586/38 | TC[WOS]:13 TC[Scopus]:17 | Submit date:2018/10/30
Nagilactone e  Non-small Cell Lung Cancer  Cyclin B1  Cell Cycle  Apoptosis  
Physalin B induces cell cycle arrest and triggers apoptosis in breast cancer cells through modulating p53-dependent apoptotic pathway Journal article
BIOMEDICINE & PHARMACOTHERAPY, 2018,Volume: 101,Page: 334-341
Authors:  Wang, Anqi;  Wang, Shengpeng;  Zhou, Fayang;  Li, Peng;  Wang, Yitao;  Gan, Lishe;  Lin, Ligen
View | Adobe PDF | Favorite | View/Download:529/20 | TC[WOS]:9 TC[Scopus]:12 | Submit date:2018/10/30
Physalin b  Breast Cancer  Cell Cycle  Apoptosis  P53  Akt  
DEPDC1 is required for cell cycle progression and motility in nasopharyngeal carcinoma Journal article
ONCOTARGET, 2017,Volume: 8,Issue: 38,Page: 63605-63619
Authors:  Feng, Xuefei;  Zhang, Chundong;  Zhu, Ling;  Zhang, Lian;  Li, Hongxia;  He, Longxia;  Mi, Yan;  Wang, Yitao;  Zhu, Jiang;  Bu, Youquan
Favorite | View/Download:9/0 | TC[WOS]:10 TC[Scopus]:15 | Submit date:2018/11/01
DEPDC1  cell cycle  mitosis  nasopharyngeal carcinoma  
In sickness and in health: The many roles of the minichromosome maintenance proteins Journal article
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2017,Volume: 1868,Issue: 1,Page: 295-308
Authors:  Neves, Henrique;  Kwok, Hang Fai
Favorite | View/Download:25/0 | TC[WOS]:13 TC[Scopus]:16 | Submit date:2018/10/30
Co-delivery of paclitaxel and tetrandrine via iRGD peptide conjugated lipid-polymer hybrid nanoparticles overcome multidrug resistance in cancer cells Journal article
SCIENTIFIC REPORTS, 2017,Volume: 7
Authors:  Zhang, Jinming;  Wang, Lu;  Chan, Hon Fai;  Xie, Wei;  Chen, Sheng;  He, Chengwei;  Wang, Yitao;  Chen, Meiwan
View | Adobe PDF | Favorite | View/Download:544/11 | TC[WOS]:21 TC[Scopus]:32 | Submit date:2018/10/30
Luminescent iridium(III) complexes as COX-2-specific imaging agents in cancer cells Journal article
CHEMICAL COMMUNICATIONS, 2017,Volume: 53,Issue: 19,Page: 2822-2825
Authors:  Liu, Chenfu;  Yang, Chao;  Lu, Lihua;  Wang, Wanhe;  Tan, Weihong;  Leung, Chung-Hang;  Ma, Dik-Lung
View | Adobe PDF | Favorite | View/Download:557/49 | TC[WOS]:35 TC[Scopus]:37 | Submit date:2018/10/30
APC/C dysfunction limits excessive cancer chromosomal instability Journal article
Cancer Discovery, 2017,Volume: 7,Issue: 2
Authors:  Sansregret L;  Patterson JO;  Dewhurst S;  López-García C;  Koch A;  McGranahan N;  Chao WCH;  Barry DJ;  Rowan A;  Instrell R;  Horswell S;  Way M;  Howell M;  Singleton MR;  Medema RH;  Nurse P;  Petronczki M;  Swanton C
Favorite | View/Download:8/0 | TC[WOS]:38 TC[Scopus]:44 | Submit date:2018/12/18
Nanoparticle-mediated inhibition of survivin to overcome drug resistance in cancer therapy Journal article
Journal of Controlled Release, 2016,Volume: 240,Page: 454
Authors:  Wang S.;  Xu Y.;  Chan H.F.;  Kim H.-W.;  Wang Y.;  Leong K.W.;  Chen M.
Favorite | View/Download:23/0 | TC[WOS]:25 TC[Scopus]:31 | Submit date:2018/10/31
Apoptosis  Cancer  Drug Resistance  Nanoparticles  Survivin